Professional Documents
Culture Documents
Options for first trimester screening for Down syndrome therefore include providing either a
fetus-specific risk based on nuchal translucency alone, or providing an overall overall
pregnancy risk based on combined serum and sonographic markers
Second Trimester Screening for Aneuploidy
• Options for second trimester screening include serum screening using
the Quad test (alphafetoprotein, human chorionic gonadotropin,
unconjugated estriol, and inhibin-A), sonographic screening using the
so-called Genetic Sonogram, and combinations of serum and
sonographic screening.
The sonographic approach to establishing the presence or absence of
each of the commonly utilized minor markers is summarized below:
1. Nuchal fold
2. Echogenic bowel
3. Humerus and femur length
4. Echogenic intracardiac focus
5. Pyelectasis
6. Nasal bones
7. Choroid plexus cyst
COMBINED FIRST AND SECOND
TRIMESTER SCREENING
• Integrated Screening
• Stepwise Screening
• Contingent Screening
SECOND TRIMESTER SCREENING IN
MULTIPLE GESTATIONS
• Interpretation of maternal serum screening, however, can be difficult
because of the potential for discordancy between twins and the impact of
different placentas on the various analytes. On average, second trimester
levels of the commonly utilized biochemical markers are twice as high as in
singleton pregnancies.
• In dichorionic pregnancies, if one fetus is euploid and another is aneuploid,
the opposite direction in which biochemical markers from individual
placentas go may be masked by the overall maternal serum levels.
• Maternal serum markers may be interpretable however using the
“pseudorisk” approach. This involves dividing the observed multiple of the
median (MoM) values found in each twin pregnancy being evaluated, by
the median value found in normal singletons.